Linked Data API

Show Search Form

Search Results

1142924
star this property registered interest false more like this
star this property date less than 2019-09-02more like thismore than 2019-09-02
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what alternative arrangements will be introduced in the new local pharmacy contract to safeguard people taking multiple medications and ensure they receive a regular review of their medication to prevent contraindications. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 284342 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-09-09more like thismore than 2019-09-09
star this property answer text <p>Medicines Usage Reviews (MURs) are adherence centred reviews with the community pharmacist in isolation from the prescriber. The new Structured Medication Reviews, offered by clinical pharmacists working in primary care networks (PCNs), will provide a more comprehensive review of a patient’s medication with access to the patient record and with the greater ability of clinical pharmacists to make independent decisions to change medication, if that is the result of a review. It is expected that community pharmacists and practice-based pharmacists will work closely together to optimise medicines usage.</p><p>Recently announced changes to the Community Pharmacy Contractual Framework, include a Medicines Reconciliation Service, through which community pharmacists will be expected to collaborate with PCN pharmacists and prescribers, to ensure patients are clear about changes to their medicines, post-discharge, in line with the National Institute for Health and Care Excellence guideline on medicines optimisation. The Pharmacy Quality Scheme and the general practice Quality and Outcomes Framework Quality Improvement modules incentivise PCNs and community pharmacy to identify those taking high risk medicines and take actions to reduce risks where appropriate.</p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-09-09T15:31:26.97Zmore like thismore than 2019-09-09T15:31:26.97Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
1142923
star this property registered interest false more like this
star this property date less than 2019-09-02more like thismore than 2019-09-02
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of scrapping Medicines Usage Reviews on people who take multiple medications. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 284398 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-09-09more like thismore than 2019-09-09
star this property answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-09-09T17:30:47.47Zmore like thismore than 2019-09-09T17:30:47.47Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
1107748
star this property registered interest false more like this
star this property date less than 2019-03-29more like thismore than 2019-03-29
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Prescriptions more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the variation between Clinical Commissioning Groups of the availability of emollients on prescription. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 238640 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-04-05more like thismore than 2019-04-05
star this property answer text <p>The Department and NHS England expects clinical commissioning groups (CCGs) to take both NHS England and National Institute for Health and Care Excellence guidance into account in formulating local polices, and for prescribers to reflect local policies in their prescribing practice.</p><p> </p><p>In March 2018, CCG guidance was published on conditions for which over the counter items should not be routinely prescribed in primary care. This covers 35 minor conditions, including recommendations on the use of emollients for self-care of mild dry skin. The recommendation in this guidance only applies to those with mild dry skin or mild irritant dermatitis. If CCGs have implemented the guidance as intended, patients with moderate to severe eczema will still be able to receive their emollients on prescription as it is a chronic condition.</p><p> </p><p>NHS England has also recently run a consultation on ‘Items which should not routinely be prescribed in primary care: an update and a consultation on further guidance for clinical commissioning groups (CCGs)’. This included proposals around the proscribing of emollient bath and shower preparations (it did not cover all emollients, which come in a range of other formulations).</p><p> </p><p>Variation of prescribing of emollient bath and shower preparations was reviewed and published as part of the consultation undertaken from 28 November 2018 – 28 February 2019. Details of this are available in the consultation document at the following link:</p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/user_uploads/low-priority-prescribing-consultation-guidance.pdf" target="_blank">https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/user_uploads/low-priority-prescribing-consultation-guidance.pdf</a></p><p> </p><p>NHS England is currently taking account of all consultation responses and updated CCG guidance is due to be published in the summer of 2019.</p>
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property grouped question UIN 239233 more like this
star this property question first answered
less than 2019-04-05T11:04:45.48Zmore like thismore than 2019-04-05T11:04:45.48Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
833870
star this property registered interest false more like this
star this property date less than 2018-01-30more like thismore than 2018-01-30
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NICE on the time taken to issue guidance once a marketing authorisation has been granted. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 125628 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-02-07more like thismore than 2018-02-07
star this property answer text <p>Departmental officials regularly meet with officials in the National Institute for Health and Care Excellence (NICE) to discuss a range of issues, including the timescales for the development of guidance through its technology appraisal (TA) and highly specialised technology (HST) programmes.</p><p> </p><p>Wherever possible, NICE aims to publish TA and HST guidance on new drugs and significant licence extensions within a few months of a drug receiving a marketing authorisation.</p><p> </p><p>The new arrangements for the assessment and adoption of cancer drugs introduced in July 2016 mean that the NICE appraisal process now starts much earlier for newly referred drugs, with the aim of publishing draft guidance before drugs receive their licence, and then final guidance to be issued within 90 days of that.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-02-07T14:03:15.937Zmore like thismore than 2018-02-07T14:03:15.937Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
938471
star this property registered interest false more like this
star this property date less than 2018-07-11more like thismore than 2018-07-11
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what information on the costs of goods he will require of manufacturers of special medicinal products under the Health Service Medical Supplies (Costs) Act 2017 and subsequent regulations; and if he will bring forward further regulatory proposals to control the costs of those products. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 163104 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-07-16more like thismore than 2018-07-16
star this property answer text <p>Under the Health Service Products (Provision and Disclosure of Information) Regulations 2018, manufacturers, importers and wholesalers of special medicinal products are required to provide the Department, every quarter, with purchase and/or sales information about products already listed with a price in the Drug Tariff and products that are being considered for listing with a price in the Drug Tariff. This information will be used to inform the reimbursement prices for special medicinal products. In addition, under the same Regulations, the Department can request ad-hoc information about sales and purchases as well as costs about any special medicinal products.</p><p> </p><p>The Health Service Medical Supplies (Costs) Act 2017 enables the Government to reimburse for specials dispensed in primary care in different ways such as considering quotes of suppliers and not reimbursing pharmacies at all if, for example, they have been provided the medicine by a central service. We are developing proposals, which will be subject to consultation with relevant stakeholders.</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-07-16T16:18:06.73Zmore like thismore than 2018-07-16T16:18:06.73Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
851702
star this property registered interest false more like this
star this property date less than 2018-02-28more like thismore than 2018-02-28
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Nusinersen more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what progress NHS England and Biogenon have made in discussions on a managed access agreement for the use of Spinraza for the treatment of spinal muscular atrophy. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 130465 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-03-05more like thismore than 2018-03-05
star this property answer text <p>NHS England has advised that it is continuing discussions with Biogen and the National Institute for Health and Care Excellence about the use of nusinersen (Spinraza) for the treatment of patients with spinal muscular atrophy.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-03-05T15:54:12.893Zmore like thismore than 2018-03-05T15:54:12.893Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
935055
star this property registered interest false more like this
star this property date less than 2018-07-05more like thismore than 2018-07-05
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Alcoholic Drinks: Misuse more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what progress he has made on developing a national strategy to address alcohol consumption in line with recommendation 4 of the Cancer Strategy; and if he will make a statement. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 161161 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-07-12more like thismore than 2018-07-12
star this property answer text <p>The Government remains committed to tackling all-alcohol related harms, including cancer, which is why we are developing a new alcohol strategy. Ministers and officials are currently engaged in a series of meetings with stakeholders in the development of the strategy, which we hope to be able to publish early next year.</p><p> </p><p>The United Kingdom Chief Medical Officers’ low risk drinking guidelines were published in 2016 to provide the public with the most up to date scientific information to help people make informed decisions about their own drinking. The Department subsequently issued guidance in March 2017 setting out how the guidelines can be communicated on alcohol labels to better inform consumers. We will work with industry partners during the development of the strategy on promoting dissemination of the guidelines.</p><p> </p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property grouped question UIN 161162 more like this
star this property question first answered
less than 2018-07-12T13:52:17.203Zmore like thismore than 2018-07-12T13:52:17.203Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
1107749
star this property registered interest false more like this
star this property date less than 2019-03-29more like thismore than 2019-03-29
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Dermatitis: Prescriptions more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effect on the treatment of eczema of the availability of emollients on prescription. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 238641 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-04-05more like thismore than 2019-04-05
star this property answer text <p>No assessment has been made.</p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-04-05T11:06:17.96Zmore like thismore than 2019-04-05T11:06:17.96Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
839251
star this property registered interest false more like this
star this property date less than 2018-02-08more like thismore than 2018-02-08
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Fentanyl: Misuse more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent steps the Government has taken to tackle the misuse of Fentanyl. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 127805 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-02-20more like thismore than 2018-02-20
star this property answer text <p>Public Health England supports local areas in responding to the threat from fentanyl, and other drugs. This includes ensuring wider availability of the opioid-overdose antidote naloxone, providing messages to use with people at risk, and issuing public health alerts when there is sufficient evidence of harm from particular drugs like fentanyl.</p><p>Local authorities are responsible for commissioning drug treatment services and interventions to reduce drug-related harm, based on local need.</p><p>My Rt. hon. Friend the Home Secretary has also asked the Advisory Council on the Misuse of Drugs to investigate the risks around fentanyl analogues, so we can maximise the effectiveness of our response.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-02-20T17:15:15.64Zmore like thismore than 2018-02-20T17:15:15.64Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
1135987
star this property registered interest false more like this
star this property date less than 2019-07-01more like thismore than 2019-07-01
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Staff more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure (b) specialist roles and (b) Parkinson’s nurses are included in the NHS workforce plan. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 271535 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-04more like thismore than 2019-07-04
star this property answer text <p>The National Health Service interim People Plan was published on 3 June 2019, it puts staff at the heart of NHS policy and delivery and recognises the current shortage of nurses as the most urgent challenge facing the health system.</p><p> </p><p>It calls for action to be taken now to make the NHS the best place to work, by reforming the culture and leadership and ensuring all staff (including nurses) feel supported and valued, in an effort to increase workforce recruitment and retention.</p><p> </p><p>The interim Plan proposes to increase the number of newly qualified NHS nurses, support and retain existing nurses, provide nurses with every opportunity to return to work, and bring in nurses from abroad. It commits to delivering 5,000 additional placements for nursing students, 7,500 further Nursing Associates, increasing undergraduate supply and broadening routes into nursing.</p><p> </p><p>There are no post-registration requirements for a Registered Nurse to become a Parkinson’s nurse. Therefore, local integrated care systems will be responsible for ensuring they have the necessary numbers of Parkinson’s (and other specialist) nurses to meet the needs of their local population.</p><p> </p><p> </p><p> </p>
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond more like this
star this property grouped question UIN 271536 more like this
star this property question first answered
less than 2019-07-04T11:27:08.23Zmore like thismore than 2019-07-04T11:27:08.23Z
star this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this